Experiment 1179524
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | COBLEIGH,MA: HILL,JH: LAD,TE: SHEVRIN,DE: APPLEBAUM,EL:. (1987). PHASE II STUDY OF ETOPOSIDE IN PREVIOUSLY UNTREATED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.. 71(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II CLINICAL TRIAL, ETOPOSIDE WAS EVALUATED AS A SINGLE AGENT THERAPY IN PREVIOUSLY UNTREATED SQUAMOUS CELL CARCINOMA. THE DOSE, ADMINISTERED AS AN INFUSION OVER 45 MINUTES, WAS SCHEDULED DAILY FOR FIVE DAYS AT THREE WEEK INTERVALS. OF FOURTEEN PATIENTS EVALUABLE FOR RESPONSE, THERE WERE ELEVEN DISEASE PROGRESSIONS. TWO PATIENTS DIED, ONE FROM DRUG RELATED NEUTROPENIC INFECTION. TWO PATIENTS HAD STABLE DISEASE. TOXICITY WAS DESCRIBED AS MILD. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |